Abstract Body

Background: CD4+ T-cells from HIV-infected individuals on antiretroviral therapy (ART) expressing the Immune Checkpoint (IC) marker of T-cell activation PD1, are preferentially infected [Chomont Nat Med 2009]. Characterizing the role of PD1 and other IC in HIV persistence during ART may identify new potential targets for eliminating latently infected T cells. Using an in vitro model of latency, we aimed to define the mechanism of how PD1 and other IC contribute to the establishment and maintenance of latent infection of both proliferating and non-proliferating T-cells.

Methods: Resting CD4+ T-cells, isolated from blood of HIV-negative individuals, labelled with the proliferation dye eFluor670, were cultured alone, with autologous blood myeloid dendritic cells (mDC) or monocytes for 24h with staphyloccocal enterotoxin B (SEB). Cells were infected with CCR5-tropic eGFP-reporter virus. Expression of IC ligands including PDL1/PDL2 (ligands for PD1), CD80/CD86 (ligand for CTLA4), Galectin 9 (possible ligand for Tim3) and herpes virus entry mediator; HVEM (ligand for B and T cell attenuator (BTLA)) on mDC and monocytes were measured at baseline and 24h post infection. Non-productively-infected, non-proliferating (eGFP–eFluor670hi) and proliferating (eGFP–eFluor670lo) T-cells were sorted by flow cytometry day 5 post infection and further sorted on the basis of IC expression, including PD1, Tim3, CTLA4, BTLA, TIGIT or LAG3. Inducible latent infection was quantified by measuring eGFP expression in sorted subsets after αCD3/CD28+IL-7+IL-2 activation and integrase inhibitor L8.

Results: Ligands for all IC were expressed, albeit at differing levels, on mDC and monocytes 24h post T-cell co-culture and HIV infection. Post integration latency in non-proliferating CD4+ T-cells was significantly enriched in cells positive for PD1 (mean fold change in eGFP expression compared to PD1 negative (MFC) =39, p=0.02, n=5), Tim3 (MFC=3.4, p=0.04, n=6), CTLA-4 (MFC=4.4, p=0.01, n=4) or BTLA (MFC=4.2, p=0.004, n=6) but not TIGIT (MFC=2.9, p=0.24, n=5) or LAG3 (MFC=2.9, p=0.67, n=3). Post integration latency in proliferating T-cells was significantly enriched in cells expressing PD1 (MFC=2.8, p=0.04, n=5) but not other IC.

Conclusions: This in vitro model of HIV latency shows PD1 to be preferentially expressed on both non-proliferating and proliferating latently infected T-cells. Interventions that alter expression or function of PD1 should be explored to eliminate latency.